Pharmaceutical Investing Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse
Pharmaceutical Investing Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2017 Financial Results
Pharmaceutical Investing Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse
